Clinical Trial Update: Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and Ribavirin

View source ↗

Summary

A completed clinical trial evaluating histologic changes and noninvasive assessment in chronic hepatitis C patients treated with peginterferon alfa-2a and ribav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Seoul National University Boramae Hospital | Conditions: Chronic Hepatitis C | Status: COMPLETED